BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 872621)

  • 41. Systemic reactions to stinging ants.
    Lockey RF
    J Allergy Clin Immunol; 1974 Sep; 54(3):132-46. PubMed ID: 4854598
    [No Abstract]   [Full Text] [Related]  

  • 42. Venom immunotherapy.
    Reisman RE
    JAMA; 1980 Aug 22-29; 244(8):769. PubMed ID: 7392181
    [No Abstract]   [Full Text] [Related]  

  • 43. Case report of venom immunotherapy for a patient with large local reactions.
    Hamilton RG; Golden DB; Kagey-Sobotka A; Lichtenstein LM
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):134-7. PubMed ID: 11527245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.
    Wanandy T; Mulcahy E; Lau WY; Brown SGA; Wiese MD
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):123-144. PubMed ID: 34075569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venom Hypersensitivity.
    Wilson JL; Wilson B
    Prim Care; 2023 Jun; 50(2):305-324. PubMed ID: 37105609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defense of whole body extract in hyposensitization to insect venom.
    Frazier CA
    Cutis; 1977 Jun; 19(6):789-91. PubMed ID: 872623
    [No Abstract]   [Full Text] [Related]  

  • 47. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hazards of hymenoptera.
    Frazier CA
    Am Fam Physician; 1977 Apr; 15(4):91-6. PubMed ID: 848424
    [No Abstract]   [Full Text] [Related]  

  • 51. Ant, bee, and wasp stings.
    Elgart GW
    Dermatol Clin; 1990 Apr; 8(2):229-36. PubMed ID: 2191796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy control of specific hymenoptera venom allergy].
    Aust W; Wichmann G; Dietz A
    Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hymenoptera hypersensitivity in an imported fire ant endemic area.
    Freeman TM
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):369-72. PubMed ID: 9109704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Venom immunotherapy--a critical evaluation of in vitro techniques.
    Small P; Barrett D; Biskin N
    Ann Allergy; 1983 Apr; 50(4):256-9. PubMed ID: 6838023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A 5-year venom immunotherapy protocol with 50 μg maintenance dose: safety and efficacy in school children.
    Konstantinou GN; Manoussakis E; Douladiris N; Hatziioannou A; Giavi S; Saxoni-Papageorgiou P; Papadopoulos NG
    Pediatr Allergy Immunol; 2011 Jun; 22(4):393-7. PubMed ID: 21235631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial.
    Brown SG; Wiese MD; van Eeden P; Stone SF; Chuter CL; Gunner J; Wanandy T; Phillips M; Heddle RJ
    J Allergy Clin Immunol; 2012 Jul; 130(1):162-8. PubMed ID: 22460067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stinging insect hypersensitivity. Safety and efficacy of venom immunotherapy.
    Golub JR; Kaplan SR; Mascia AV
    N Y State J Med; 1984 Feb; 84(2):66-8. PubMed ID: 6583559
    [No Abstract]   [Full Text] [Related]  

  • 60. Insect sting allergy and venom immunotherapy: a model and a mystery.
    Golden DB
    J Allergy Clin Immunol; 2005 Mar; 115(3):439-47; quiz 448. PubMed ID: 15753884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.